Wave Life Sciences (WVE) Net Margin Growth (1y) (2016 - 2026)
Wave Life Sciences (WVE) Net Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 447.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 673.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,097.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,208.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,636.00 |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - | -247,243.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -247,243.00 |
| Mar 31, 2026 | 44,272.00 |
| Jun 30, 2025 | -41,298.00 |
| Mar 31, 2025 | -25,923.00 |
| Jun 30, 2024 | -7,172.00 |
| Mar 31, 2024 | -3,973.00 |
| Dec 31, 2023 | 347,174.00 |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 194,883.00 |
| Dec 31, 2022 | -155,672.00 |
| Sep 30, 2022 | -1.37 Mn |
| Jun 30, 2022 | -961,580.00 |
| Dec 31, 2021 | -166,605.00 |
| Sep 30, 2021 | 94,232.00 |
| Jun 30, 2021 | -5,759.00 |
| Dec 31, 2020 | 206,042.00 |
| Sep 30, 2020 | 77,243.00 |
| Jun 30, 2020 | -78,904.00 |
| Mar 31, 2020 | 31,929.00 |